- Report
- October 2024
- 186 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 184 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- March 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- March 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- May 2024
- 137 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- December 2024
- 140 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Report
- October 2024
- 169 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- September 2024
- 343 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- January 2023
- 130 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- September 2021
- 40 Pages
China
From €2493EUR$2,600USD£2,083GBP
- Report
- November 2021
- 101 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- February 2024
- 30 Pages
Global
€3403EUR$3,550USD£2,844GBP
- Report
- November 2023
- 30 Pages
Global
From €2636EUR$2,750USD£2,203GBP
- Report
- August 2022
- 155 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Report
- January 2022
- 130 Pages
Global
From €6663EUR$6,950USD£5,567GBP
- Report
- August 2022
- 120 Pages
Global
From €4554EUR$4,750USD£3,805GBP

Budesonide is a corticosteroid used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is available in both inhalation and oral forms, and is used to reduce inflammation in the airways. Budesonide is a synthetic corticosteroid, meaning it is similar to the hormones produced naturally by the body. It works by reducing inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath.
Budesonide is a widely used drug in the respiratory market, and is often prescribed as a first-line treatment for asthma and COPD. It is generally well-tolerated and has fewer side effects than other corticosteroids. It is also used in combination with other drugs to treat more severe cases of respiratory diseases.
Some companies in the Budesonide market include AstraZeneca, GlaxoSmithKline, Merck, and Teva Pharmaceuticals. Show Less Read more